Chimeric Antigen Receptor T Cell Therapy
Chimeric antigen receptor (CAR) T cell therapy has stirred a hot debate in clinic since the first CAR T cell therapy for patients with acute lymphoblastic leukemia (ALL) got approval from FDA in August 2017. This video is going to introduce what this treatment is and how it works.
Publish: 2017/12/22
CAR T Cell Therapy: Efficacy & Safety
Chimeric antigen receptor (CAR) T cell therapy has great potential, but its efficacy and safety are the remaining issues. Researchers are working on developing strategies to improve the therapy. Take a look at this video and learn the structure of CAR and efficacy/safety of CAR T cell therapy.
Publish: 2018/1/4
What are circulating tumor cells (CTCs)? Why the cells become popular in cancer research? The video shows a brief introduction to CTC, which is a hot topic in medicine.
Publish: 2017/12/5
Circulating Tumor Cell Isolation
Immunological method includes three different ways to isolate circulating tumor cells with different antibodies, such as EpCAM antibody, CD45/CD41 antibody and CSV antibody.
Publish: 2017/12/13
Cellular metabolism consists of various chemical transformations. This video is going to give you a brief introduction of the different metabolic configurations in T cells.
Publish: 2018/1/16